Skip to main content
NTRA
NASDAQ Life Sciences

Natera Beats on 34% Revenue Growth, Lifts 2026 Guidance by $140M

Tom Rudovsky · Reported by BusinessWire
More coverage: Diagnostics & Research Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$363.76
Mkt Cap
$52.434B
52W Low
$181
52W High
$437.408
52W Position info
101% above low
Off High info
17% below high
Rel. Volume info
1.9× avg
Market data snapshot near publication time

NTRA has more than doubled off its 52-week low of $181 on elevated volume (1.9× avg).

Summary

Natera posted Q3 2026 revenue of $794.0 million, up 34.1% from $592.2 million a year ago, and raised full-year 2026 revenue guidance by $140 million at the midpoint to $3.005-$3.035 billion. Oncology test volume did the heavy lifting: roughly 339,500 tests processed, up 60.9%, with clinical MRD units adding 32,700 sequentially. Gross margin held at 64.7%, and the net loss narrowed to $59.9 million, or $0.42 per share, from $87.5 million a year earlier. Cash rose about $5.7 million sequentially to $1.097 billion, and management guided to positive cash flow for the year. The guidance raise is the number that matters — it implies the reimbursement wins, including the recent CMS MolDX coverage for serial Signatera testing in hepatocellular carcinoma, are converting into revenue faster than the Street modeled. Watch the 4:30 p.m. ET call for detail on the size of the true-up benefit and oncology ASP trends.

At the time of this announcement, NTRA was trading at $363.76 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $52.4B. The 52-week trading range was $181.00 to $437.41. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: BusinessWire.


Price Chart

Share this article

Copied!

NTRA - Latest Insights

NTRA
Nov 06, 2026, 11:25 AM EST
Source: Benzinga
Importance Score:
7
Price at Filing: $316.02
Real-time Price: $274.10 info
Change: -$41.92 (-13%) info
Market Cap: $39.751B info
NTRA
Nov 05, 2026, 4:49 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $293.97
Real-time Price: $274.10 info
Change: -$19.87 (-7%) info
Market Cap: $39.751B info
NTRA
Nov 05, 2026, 4:06 PM EST
Source: BusinessWire
Importance Score:
7
Price at Filing: $366.75
Real-time Price: $274.10 info
Change: -$92.65 (-25%) info
Market Cap: $39.751B info
NTRA
Nov 03, 2026, 7:00 AM EST
Source: BusinessWire
Importance Score:
7
Price at Filing: $380.77
Real-time Price: $274.10 info
Change: -$106.67 (-28%) info
Market Cap: $39.751B info
NTRA
Oct 09, 2026, 8:00 AM EDT
Source: BusinessWire
Importance Score:
7
Price at Filing: $391.54
Real-time Price: $274.10 info
Change: -$117.44 (-30%) info
Market Cap: $39.751B info